- Home
- CADL vs EMX Comparison
CADL vs EMX Comparison
Compare CADL & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- EMX
- Stock Information
- Founded
- CADL 1999
- EMX N/A
- Country
- CADL United States
- EMX Canada
- Employees
- CADL N/A
- EMX N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- CADL Health Care
- EMX
- Exchange
- CADL Nasdaq
- EMX Nasdaq
- Market Cap
- CADL 313.5M
- EMX 338.0M
- IPO Year
- CADL 2021
- EMX N/A
- Fundamental
- Price
- CADL $4.79
- EMX $4.18
- Analyst Decision
- CADL Strong Buy
- EMX Strong Buy
- Analyst Count
- CADL 5
- EMX 2
- Target Price
- CADL $19.80
- EMX $5.38
- AVG Volume (30 Days)
- CADL 724.9K
- EMX 943.2K
- Earning Date
- CADL 08-14-2025
- EMX 11-06-2025
- Dividend Yield
- CADL N/A
- EMX N/A
- EPS Growth
- CADL N/A
- EMX N/A
- EPS
- CADL N/A
- EMX 0.04
- Revenue
- CADL N/A
- EMX $29,864,000.00
- Revenue This Year
- CADL N/A
- EMX $11.08
- Revenue Next Year
- CADL N/A
- EMX $3.72
- P/E Ratio
- CADL N/A
- EMX $94.35
- Revenue Growth
- CADL N/A
- EMX N/A
- 52 Week Low
- CADL $3.79
- EMX $1.64
- 52 Week High
- CADL $14.60
- EMX $4.44
- Technical
- Relative Strength Index (RSI)
- CADL 32.97
- EMX 72.14
- Support Level
- CADL $4.81
- EMX $4.01
- Resistance Level
- CADL $5.01
- EMX $4.44
- Average True Range (ATR)
- CADL 0.30
- EMX 0.18
- MACD
- CADL -0.08
- EMX 0.04
- Stochastic Oscillator
- CADL 3.18
- EMX 77.19
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.